Fundz

BioCryst Pharmaceuticals

Durham, North Carolina, United States · Biotechnology, Health Care, Therapeutics

BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
Durham, North Carolina, United States
Employees
440
Industries
Biotechnology, Health Care, Therapeutics
Status
Public (BCRX)
Website
http://www.biocryst.com/
LinkedIn
Company page

Recent activity at BioCryst Pharmaceuticals

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Employee benefit plans

BioCryst Pharmaceuticals files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

About BioCryst Pharmaceuticals: questions and answers

What does BioCryst Pharmaceuticals do?

BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.

Where is BioCryst Pharmaceuticals headquartered?

BioCryst Pharmaceuticals is headquartered in Durham, North Carolina, United States.

How many employees does BioCryst Pharmaceuticals have?

BioCryst Pharmaceuticals has about 440 employees.

What is the latest news on BioCryst Pharmaceuticals?

On Aug 29, 2026, BioCryst acquires Astria Therapeutics for drug access

Is BioCryst Pharmaceuticals a public company?

Yes. BioCryst Pharmaceuticals is publicly traded under the ticker BCRX.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches BioCryst Pharmaceuticals across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.